IP Verse

Novartis Gene Therapies, Inc. et al. vs Genzyme Corporation et al.

The detailed information for PTAB case with proceeding number IPR2023-01044 filed by Novartis Gene Therapies, Inc. et al. against Genzyme Corporation et al. on Jun 30, 2023. This includes filing dates, application numbers, tech centers, patent numbers, and current case status.

Case Details

Proceeding Number
IPR2023-01044
Filing Date
Jun 30, 2023
Petitioner
Novartis Gene Therapies, Inc. et al.
Respondent
Genzyme Corporation et al.
Status
Terminated-Settled
Respondent Application Number
15544498
Respondent Tech Center
1600
Respondent Patent Number
10429288
Institution Decision Date
Jan 9, 2024
Termination Date
Mar 4, 2024

Proceeding Documents

The table below shows documents filed in the case, listing each document name, filing date, document type, and filing party. Tracking these filings indicates the activity of the parties involved in the case, and the types of documents filed can provide insights into the legal strategies being employed.


Document NameFiling DateCategoryFiling Party

Alert me when new update on this case

Termination Decision: Post-DI Settlement

Mar 4, 2024PAPERBOARD

Joint Motion to Terminate

Feb 26, 2024PAPERPETITIONER

Confidential Settlement and License Agreement

Feb 26, 2024EXHIBITPETITIONER

Joint Request That Settlement Agreement Be Treated As Business Confidential Information And Kept Separate

Feb 26, 2024PAPERPETITIONER

Petitioners' Updated Exhibit List

Feb 26, 2024PAPERPETITIONER

Order: Authorizing the Filing of a Joint Motion to Terminate - 35 USC 317;,37 CFR 42.20(b), 42.72

Feb 21, 2024PAPERBOARD

Ex. 3101

Feb 15, 2024EXHIBITBOARD

Order Granting Request for Withdrawal of Director Review of Institution Decision

Feb 15, 2024PAPERBOARD

Ex. 3100

Jan 24, 2024EXHIBITBOARD

PATENT OWNER’S OBJECTIONS TO EVIDENCE FILED WITH THE PETITION

Jan 24, 2024PAPERPATENT OWNER

Petitioners' Objections to Patent Owner's Evidence

Jan 24, 2024PAPERPETITIONER

Patent Owner's Request for Rehearing by the Director

Jan 23, 2024PAPERPATENT OWNER

Order: SCHEDULING ORDER

Jan 17, 2024PAPERBOARD

DECISION Granting Institution of Inter Partes Review 35 U.S.C. § 314, 37 C.F.R. § 42.4

Jan 9, 2024PAPERBOARD

Patent Owner's Preliminary Response

Oct 11, 2023PAPERPATENT OWNER

Declaration of Jeffrey C. Hansen

Oct 11, 2023EXHIBITPATENT OWNER

Hansen CV

Oct 11, 2023EXHIBITPATENT OWNER

Burnham (2015)

Oct 11, 2023EXHIBITPATENT OWNER

Collaud (2018)

Oct 11, 2023EXHIBITPATENT OWNER

Spies (2020)

Oct 11, 2023EXHIBITPATENT OWNER

Xie (2002)

Oct 11, 2023EXHIBITPATENT OWNER

Sommer (2003)

Oct 11, 2023EXHIBITPATENT OWNER

Matsushita (2008)

Oct 11, 2023EXHIBITPATENT OWNER

Wright (2014)

Oct 11, 2023EXHIBITPATENT OWNER

Notice: Notice filing date accorded

Jul 11, 2023PAPERBOARD

Notice : Power of Attorney

Jul 11, 2023PAPERPATENT OWNER

Notice : Mandatory Notice

Jul 11, 2023PAPERPATENT OWNER

US 10,429,288

Jun 30, 2023EXHIBITPETITIONER

288 File History

Jun 30, 2023EXHIBITPETITIONER

WO 2014/125101 A1

Jun 30, 2023EXHIBITPETITIONER

Berkowitz 2007

Jun 30, 2023EXHIBITPETITIONER

Cole 2008

Jun 30, 2023EXHIBITPETITIONER

Cole 1999

Jun 30, 2023EXHIBITPETITIONER

Schuck 2000

Jun 30, 2023EXHIBITPETITIONER

Gao 2014

Jun 30, 2023EXHIBITPETITIONER

Hoque 1999

Jun 30, 2023EXHIBITPETITIONER

Glybera Assessment Report 2012

Jun 30, 2023EXHIBITPETITIONER

Berkowitz 2015

Jun 30, 2023EXHIBITPETITIONER

Third Party Observation for Application Number EP20160703205

Jun 30, 2023EXHIBITPETITIONER

Introduction to Analytical Ultracentrifugation

Jun 30, 2023EXHIBITPETITIONER

Steinbach 1997

Jun 30, 2023EXHIBITPETITIONER

US 2009/0017542 A1

Jun 30, 2023EXHIBITPETITIONER

Zhao 2013

Jun 30, 2023EXHIBITPETITIONER

McCarty 2008

Jun 30, 2023EXHIBITPETITIONER

Dafforn 2006

Jun 30, 2023EXHIBITPETITIONER

Gombold 2006

Jun 30, 2023EXHIBITPETITIONER

Petition for Inter Partes Review

Jun 30, 2023PAPERPETITIONER

Petitioner's Supplemental Paper and Notice Ranking Petitions

Jun 30, 2023PAPERPETITIONER

Petitioner Novartis Gene Therapies, Inc.'s Power of Attorney

Jun 30, 2023PAPERPETITIONER

Petitioner Novartis Pharmaceuticals Corporation's Power of Attorney

Jun 30, 2023PAPERPETITIONER

Petitioner's Exhibit List

Jun 30, 2023PAPERPETITIONER

Berkowitz Declaration

Jun 30, 2023EXHIBITPETITIONER